Tech Scrape

New software aims to expose mobile malware by monitoring a device’s memory usage. Yesterday at the RSA Conference in San Francisco, a researcher presented a new way to detect malware on mobile devices. He says it can catch even unknown pests and can protect a device without draining its battery or taking up too much processing power.

1366 Technologies hopes to cut the cost of solar with cheaper manufacturing. A new manufacturing process could cut the cost of making crystalline silicon wafers for solar cells by 80 percent. The process is being developed by Lexington, MA-based 1366 Technologies , which this week showed off the first solar cells made this way. The technology is key to the company’s plan to make solar power cheaper than the electricity generated from coal within 10 years.

The fluorescent molecule targets tumors to guide surgeons and provide pre- and post-op imaging. A new molecule designed to seek out and label cancer cells could help guide surgeons to hidden pockets of disease–a technology that could one day allow for more complete tumor removal and increase a patient’s chances of survival.

Experiments in mice show that the brain’s ability to adapt might not disappear with age. Transplanting fetal neurons into the brains of young mice opens a new window on neural plasticity, or flexibility in the brain’s neural circuits. The research, published today in the journal Science , suggests that the brain’s ability to radically adapt to new situations might not be permanently lost in youth, and helps to pinpoint the factors needed to reintroduce this plasticity .

A novel optical device could ultimately be used to treat neurological disease. Researchers at Medtronic are developing a prototype neural implant that uses light to alter the behavior of neurons in the brain. The device is based on the emerging science of optogenetic neuromodulation, in which specific brain cells are genetically engineered to respond to light. Medtronic, the world’s largest manufacturer of biomedical technologies, aims to use the device to better understand how electrical therapies, currently used to treat Parkinson’s and other disorders, assuage symptoms of these diseases. Medtronic scientists say they will use the findings to improve the electrical stimulators the company already sells, but others ultimately hope to use optical therapies directly as treatments.

The money has helped the solar and wind industries, but hasn’t created many manufacturing jobs. In the year since it was enacted by Congress, the federal stimulus bill has helped the solar and wind markets grow in the United States, but has done relatively little to boost domestic renewable energy manufacturing.

New technology being tested could provide a noninvasive approach to treating stroke. An ultrasound device designed to produce highly focused sound waves might one day be used to break up stroke-causing blood clots in the brain without surgery or drugs. So far, the system has only been tested on clots in test tubes and animals, but researchers aim to start human tests by the end of 2011.

Cells absorb sunlight concentrated 1,000 times without cooling. A startup company hopes to bring down the cost of generating power with concentrated sunlight by using microscale solar cells that can utilize twice as much light as other panels, without the need for expensive optics or cooling systems. Panels made from the tiny cells, which the Durham, NC-based company Semprius developed using a novel microprinting technology, also offer significant savings on materials costs. In late January, the company announced a joint agreement with Siemens to develop demonstration systems based on its technology. Semprius plans to begin volume production of the modules in 2013.

Autoantibodies could alert doctors to cancer development. A new screening tool developed by scientists in Denmark may help detect the earliest stages of cancer by taking advantage of the body’s own defenses. The researchers constructed a microarray system that analyzes patients’ blood for a specific class of immune agents called autoantibodies. These are agents that attack the body’s own tissue, targeting what they perceive as “foreign” cells, such as specific molecules on the surface of tumors.

The best of the rest from the Physics arXiv this week: